Skip to main content
Equibles
VMD logo

VMD · Viemed Healthcare, Inc. · Documents

Track VMD — free

Use VMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.13 +0.12 (+1.33%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$345.96M
Shares
37.89M
Volume · Nov 6 256.08K Avg daily vol (3M) 297.71K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $270.28M up 20.5% 10-K filed Mar 4, 2026 Quarterly report New FY2026 Q3 Revenue $80.67M up 12.2% 10-Q filed Nov 4, 2026 Latest results New Financial results 8-K filed Nov 4, 2026 Earnings call New Q3 2026 earnings call Held Nov 5, 2026
2026
Nov 5
Earnings call
Record revenue drives higher earnings and raised guidance

ViMed reported record third-quarter revenue of $80.7 million and net income of $4.6 million, raised full-year revenue guidance to $316 million to $320 million, and plans maternal health expansion at two states per quarter.

4 source passages
The third quarter was another strong quarter for ViMed, with a record revenue of $80.7 million, representing 12.2% growth over last year. Net income attributable to BiMed was $4.6 million, or 11 cents per diluted share, compared with $3.5 million, or 9 cents per diluted share a year ago, and $2.8 million, or 7 cents per diluted share in the second quarter of this year. We are raising the lower end of our full-year revenue guidance and now expect revenue of $316 million to $320 million, compared with our previous range of $314 to $320 million. We are now on track to enter two additional states per quarter, beginning in the fourth quarter, establishing a regular pace of expansion. Open the document at this passage
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $80.67M ▲ 12.2% Net income $4.64M ▲ 32.0% Diluted EPS $0.11 ▲ 22.2%
Aug 3
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $78.1M ▲ 23.9% Net income $2.76M ▼ 12.4% Diluted EPS $0.07 ▼ 12.5%
May 5
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $75.41M ▲ 27.5% Net income $2.58M ▼ 1.6% Diluted EPS $0.06 ▲ unchanged
Mar 4
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $270.28M ▲ 20.5% Net income $14.93M ▲ 32.6% Diluted EPS $0.37 ▲ 32.1%
2025
Nov 5
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $71.91M ▲ 24.0% Net income $3.51M ▼ 9.4% Diluted EPS $0.09 ▼ 10.0%
Aug 6
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $63.06M ▲ 14.7% Net income $3.16M ▲ 115.1% Diluted EPS $0.08 ▲ 100.0%
May 7
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $59.13M ▲ 16.9% Net income $2.63M ▲ 63.8% Diluted EPS $0.06 ▲ 50.0%
Mar 10
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $224.26M ▲ 22.5% Net income $11.27M ▲ 10.0% Diluted EPS $0.28 ▲ 12.0%
2024
Nov 6
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $58M ▲ 17.4% Net income $3.88M ▲ 32.9% Diluted EPS $0.10 ▲ 42.9%
Aug 7
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $54.97M ▲ 26.9% Net income $1.47M ▼ 37.0% Diluted EPS $0.04 ▼ 33.3%
Showing 1–50 of 162 documents
Key facts CIK 1729149 CUSIP 92663R105 13F (30d) 67 filings 55 filers Visit website Investor relations